Aussie Research Pinpoints Source Of Aggressive Breast Cancer
This article was originally published in PharmAsia News
Australian researchers report they have traced the most aggressive forms of breast cancer to cells in the lining of mammary ducts, indicating a focus for fighting the disease. The research team at a medical research institute believes the pre-cancerous cells may be behind the cancer, instead of the disease originating in breast stem cells as generally believed. The lead researcher said the finding could lead to new drugs or other treatments for the aggressive form of the breast cancer. (Click here for more
You may also be interested in...
In a statement submitted to the Senate Finance Committee, Natural Products Association CEO Dan Fabricant suggests two ways of improving compliance with new dietary ingredient notification requirements at negligible expense to the US FDA.
Public Company Edition: Legend Biotech raised $424m in its US public market debut. Also, Pfizer commits up to $500m for equity investments and Allogene capitalizes on ASCO with a $550m offering.
US FDA investigators are more likely to cite cell and gene therapy manufacturers for facilities and production deficiencies, agency says, while industry reports difficulties complying with drug GMP requirements that are not always applicable to cell and gene therapies.